Elevance Health Aktie
| 342,44USD | -3,89USD | -1,12% |
WKN DE: A12FMV / ISIN: US0367521038
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 83 400 | 98 200 | 102 300 | 104 900 | 104 200 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,46 | 1,41 | 1,53 | 1,63 | 1,70 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 45 751 | 51 122 | 55 617 | 60 029 | 58 942 |
| Summe Anlagevermögen | 42 525 | 46 338 | 47 155 | 48 899 | 57 947 |
| Summe Aktiva | 88 276 | 97 460 | 102 772 | 108 928 | 116 889 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 55 077 | 61 332 | 66 378 | 69 523 | 75 463 |
| Summe Eigenkapital | 33 199 | 36 128 | 36 394 | 39 405 | 41 426 |
| Summe Passiva | 88 276 | 97 460 | 102 772 | 108 928 | 116 889 |
Adresse
| 220 Virginia Avenue, 46204 Indianapolis | |
| Telefon | +1 (833) 401-1577 |
| Internet | http://www.elevancehealth.com |
Management
|
Antonio Fabio Neri
Independent Director |
|
Bahija Jallal
Independent Director |
|
Bryony Winn
President-Health Solutions |
|
Chris Rigg
Senior VP & CFO-Commercial & Specialty Business |
|
Deanna Dawnette Strable-Soethout
Independent Director |
|
Dustin Wilcox
Chief Information Security Officer |
|
Felicia Farr Norwood
President-Government Health Benefits & EVP |
|
Gail Koziara Boudreaux
President, Chief Executive Officer & Director |
|
Hakon Mattson
Chief Sustainability Officer |
|
Jill A. Becher
Vice President-Planning & Execution |
|
Kathleen S. Kiefer
Secretary & Chief Governance Officer |
|
Kyle Weber
Chief Strategy Officer |
|
Lewis Hay
Independent Director |
|
Marcus D. Wilson
Chief Analytics Officer |
|
Mark B. Kaye
Chief Financial Officer & Executive Vice President |
|
Morgan Kendrick
President-Commercial Health Benefits & EVP |
|
Nathan Rich
Vice President-Investor Relations |
|
Peter David Haytaian
Executive VP, President-Carelon & CarelonRX |
|
R. Kerry Clark
Independent Director |
|
Rachel Stuve
Sr. Director Data Science & AI |
|
Ramiro G. Peru
Chairman |
|
Ratnakar Lavu
Chief Digital & Information Officer & Executive VP |
|
Robert L. Dixon
Independent Director |
|
Ronald William Penczek
Chief Accounting Officer & Controller |
|
Ryan M. Schneider
Independent Director |
|
Scott Towers
President-Dental Business |
|
Shantanu Agrawal
Chief Health Officer |
|
Steven H. Collis
Independent Director |
|
Susan D. DeVore
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.